Steven D Rubin
CIK 1381874 · Executive VP-Administration · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.06M
Companies
14
Total Filings
138
Lifetime Open-Market Net
$76.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELOX | Director | — | $13.52 | — | $0 | 7 | 2026-06-10 |
| RDVT | Director | 147,767 | $55.00 | $8.13M | -$389.3K | 11 | 2026-06-05 |
| ENTX | Director | 15,000 | $1.23 | $18.4K | $19.4K | 2 | 2026-02-17 |
| COCP | Director | 2,660,242 | $0.99 | $2.65M | $0 | 7 | 2026-01-13 |
| NAGE | Director | — | $3.45 | — | $0 | 1 | 2025-06-25 |
| OPKO HEALTH, INC. (OPKw) Delisted | Executive VP-Administration | 26,716,294 | — | — | $436.2K | 39 | 2025-05-29 |
| Niagen Bioscience, Inc. (CDXC) Delisted | Director | 7,000 | $7.87 | $55.1K | $10.2K | 10 | 2024-06-24 |
| Castle Brands Inc (ROX) Delisted | Director | 22,500 | — | — | $0 | 11 | 2019-10-09 |
| VBI Vaccines Inc/BC (VBIV) Delisted | Director | 56,250 | $0.07 | $3.7K | $0 | 4 | 2018-06-18 |
| BCDA | Interim CEO and Interim CFO | 302,822 | $0.88 | $266.5K | $0 | 1 | 2016-08-12 |
| Fluent, Inc. (IDI) Delisted | Director | 100,000 | — | — | $0 | 5 | 2016-06-03 |
| Fluent, Inc. (IDI.WS) Delisted | Director | — | — | — | $0 | 1 | 2010-01-13 |
| DREAMS INC (DRJ) Delisted | Director | — | — | — | $0 | 3 | 2009-08-05 |
| Ideation Acquisition Corp. (IDI.U) Delisted | Secretary | 157,500 | — | — | $0 | 1 | 2007-11-28 |
Recent Filings · Page 2 of 14
138 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-28 | — | Exer (M) | +3,750 | $0 | |
| 2024-11-05 | RDVT | Grant (A) | +8,000 | $0 | EDGAR |
| 2024-10-17 | — | Grant (A) | +12,000 | $0 | |
| 2024-10-11 | COCP | Grant (A) | +18,957 | $0 | EDGAR |
| 2024-07-26 | OPKO HEALTH, INC. (OPKw) Delisted | Grant (A) | +437,500 | $0 | EDGAR |
| 2024-06-24 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-26 | — | Grant (A) | — | $0 | |
| 2024-01-05 | OPKO HEALTH, INC. (OPKw) Delisted | Buy (P) | +10,000 | $8.7K | EDGAR |
| 2023-12-04 | RDVT | Grant (A) | +10,800 | $0 | EDGAR |
| 2023-11-13 | OPKO HEALTH, INC. (OPKw) Delisted | Buy (P) | +10,000 | $13.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.